AlphaGenome 2: Deciphering how cells read DNA to better understand disease

Google DeepMind has announced AlphaGenome 2, a next-generation DNA sequence model designed to predict how genetic variants affect specific human cell types and cell states. Trained on over 100 million individual cell profiles, the conditional model aims to bridge human genetics and single-cell biology to help researchers uncover cellular drivers of disease. The model is available today for non-commercial research via the AlphaGenome API and in private preview for commercial use. Open article →